Hear what healthcare professionals think about telehealth.
Through a combination of symptom review, vital sign gathering and education/health coaching aimed at the support of positive behavior change, the Health Buddy System is able to engage patients and provide context to healthcare providers which allows them to intervene before health deterioration occurs. Risk stratification of symptoms/signs, knowledge and behavior supports both early intervention and improved efficiency of data review.
Bosch’s T400 Telehealth System supports multiple daily transmissions of vital sign and symptom data to care providers for patients who require careful monitoring of compliance with care post-hospitalization.
1Baker LC, Johnson SJ, Macaulay D, Birnbaum H (2011): Integrated Telehealth and Care Management Program for Medicare Beneficiaries with Chronic Disease Linked to Savings. Health Affairs, 30 (9), 1689-1697.
2 Barnason S, Zimmerman L, Schulz P, Tu C (2009): Influence of an Early Recovery Telehealth Intervention on Physical Activity and Functioning after Coronary Artery Bypass Surgery among Older Adults with High Disease Burden. Heart Lung, 38 (5), 364-376.
3 Head BA, Studts JL, Bumpous LM, Greg JL, Wilson L, Keeney C, Schargenberger JA, Pfeifer MP (2009): Development of a Telehealth Intervention for Head and Neck Cancer Patients. Telemedicine and E-Health, 5(1), 44-52.
4 Rutherford P, Sanderson-Austin J, Smet L (2010): Intensive Care Management Supported by Technology: An Effective Approach to Managing Complex Chronic Illness. Group Practice Journal, January 2010, 9-13.
5 Trappenburg JCA, Niesink A, de Weert-vanOene GH, van den Zeijden H, van Snippenburg R, Peters A, Lammers JWJ, Schrijvers AJP (2008): Effects of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease. Telemedicine and E-Health, 14(2), 138-146.
6 Weintraub A, Gregory D, Patel AR, Levine D, Venesy D, Perry K, Delano C, Konstam MA (2010): A Multicenter Randomized Controlled Evaluation of Automated Home Monitoring and Telephonic Disease Management in Patients Recently Hospitalized For Congestive Heart Failure: The SPAN-CHF II Trial. Journal of Cardiac Failure, 16(4), 285-292.